Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sip 'til you send: study tests if drinking before surgery is safe

NCT ID NCT07656649

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 'Sip-til-Send' approach, where patients can drink small amounts of clear liquid (about a cup per hour) until called to the operating room. Researchers will use ultrasound to measure stomach volume in 120 adults and compare it to standard fasting. The goal is to see if this more liberal drinking rule changes stomach contents, which could help make fasting more comfortable without increasing rare risks like aspiration.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could support a more patient-friendly fasting guideline that allows drinking small amounts of clear liquid up until surgery, potentially improving comfort and satisfaction.
What could go wrong
This is a small, early-stage study (120 participants) measuring stomach volume, not actual aspiration risk. The results may not change official guidelines or apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Study population includes all adult patients for planned general anaesthesia or deep sedation at the day surgery unit at Haukeland University Hospital

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able to give written consent * Adult patient (\> 18 years of age) * Planned general anaesthesia or deep sedation * Fasted for at least six hours for food and two hours for clear fluids upon arrival * Expected to wait at least one hour before surgery Exclusion Criteria: * Unable to give written consent * Active gastrointestinal obstruction * Pregnancy * Ongoing opioid use * Previous stomach surgery - gastric banding / Roux-en-Y / sleeve gastrectomy * Use of GLP-1 agonist (Wegovy) * Type 1 or 2 diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fasting status are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Haukeland University Hospital

    RECRUITING

    Bergen, Vestland, 5009, Norway